These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15566456)

  • 1. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.
    Ikeda S; Douchi T; Nagata Y
    J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing superficial phlebitis during infusion of crystalloid solutions in surgical patients.
    Bass J; Freeman JB; Makarewicz P; Sproule P; Fairfull-Smith R
    Can J Surg; 1985 Mar; 28(2):124-5. PubMed ID: 3971235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip.
    Siegman-Igra Y; Jacobi E; Lang R; Schwartz D; Carmeli Y
    J Hosp Infect; 2005 Jun; 60(2):122-8. PubMed ID: 15866010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtration and infusion phlebitis: a double-blind prospective clinical study.
    DeLuca PP; Rapp RP; Bivins B; McKean HE; Griffen WO
    Am J Hosp Pharm; 1975 Oct; 32(10):1001-7. PubMed ID: 1103617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study.
    Bertolino G; Pitassi A; Tinelli C; Staniscia A; Guglielmana B; Scudeller L; Luigi Balduini C
    Worldviews Evid Based Nurs; 2012 Dec; 9(4):221-6. PubMed ID: 22390572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].
    Suga Y; Kumazaki M; Nishigami J; Takeda K; Kawagishi A; Ishizaki J; Inokuchi M; Miyamoto K; Arai K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):93-6. PubMed ID: 19151570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods of preventing phlebitis induced by infusion of fosaprepitant].
    Kohno E; Kanematsu S; Okazaki S; Ogata M; Kanemitsu M; Yamashita H; Syuntou K; Sekita M; Nishioka R; Yoshida H
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):323-6. PubMed ID: 25812501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study.
    Alpan G; Eyal F; Springer C; Glick B; Goder K; Armon J
    Pediatrics; 1984 Sep; 74(3):375-8. PubMed ID: 6433319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.
    Birnbaum J; Spies CD; Klotz E; Hein OV; Morgera S; Schink T; Ziemer S; Grund MS; Saalmann R; Kox WJ; Lehmann C
    Ren Fail; 2007; 29(3):271-7. PubMed ID: 17497439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final inline filtration: a means of decreasing the incidence of infusion phlebitis.
    Bivins BA; Rapp RP; DeLuca PP; McKean H; Griffen WO
    Surgery; 1979 Apr; 85(4):388-94. PubMed ID: 432800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical re-evaluation of effects of different treatments to prevent from phlebitis induced by Chansu injection].
    Zhao Y; Hao Z; Zhang H; Shi J; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2803-6. PubMed ID: 22292370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.